Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Relay Therapeutics, Inc. Common Stock (RLAY)

Biological Products, (no Disgnostic Substances)

https://www.relaytx.com

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

399 BINNEY STREET, 2ND FLOOR
CAMBRIDGE, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/16/2020

Market Cap

867,607,194

Shares Outstanding

127,460,000

Weighted SO

127,462,409

Total Employees

N/A

Upcoming Earnings

08/13/2024

Beta

1.6600

Last Div

0.0000

Range

5.7-12.14

Chg

-0.1900

Avg Vol

1308832

Mkt Cap

867607194

Exch

NASDAQ

Country

US

Phone

617 370 8837

DCF Diff

7.0134

DCF

-0.5434

Div Yield

0.0000

P/S

24.6423

EV Multiple

-2.1199

P/FV

1.2625

Div Yield %

0.0000

P/E

-2.6661

PEG

0.1164

Payout

0.0000

Current Ratio

15.6355

Quick Ratio

15.6355

Cash Ratio

2.9777

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

740.9480

CCC

-740.9480

Gross Margin

0.8438

Op Margin

-10.5118

Pretax Margin

-9.1692

Net Margin

-9.1692

Eff Tax Rate

-0.0558

ROA

-0.4179

ROE

-0.4366

ROCE

-0.5087

NI/EBT

1.0000

EBT/EBIT

0.8723

EBIT/Rev

-10.5118

Debt Ratio

0.0661

D/E

0.0750

LT Debt/Cap

0.0629

Total Debt/Cap

0.0697

Int Coverage

-53.3438

CF/Debt

-5.4942

Equity Multi

1.1332

Rec Turnover

0.0000

Pay Turnover

0.4926

Inv Turnover

0.0000

FA Turnover

0.5564

Asset Turnover

0.0456

OCF/Share

-2.1137

FCF/Share

-2.1325

Cash/Share

5.1830

OCF/Sales

-7.9738

FCF/OCF

1.0089

CF Coverage

-5.4942

ST Coverage

-52.6225

CapEx Coverage

-112.3413

Div&CapEx Cov

-112.3413

P/BV

1.2625

P/B

1.2625

P/S

24.6423

P/E

-2.6661

P/FCF

-3.0632

P/OCF

-3.0658

P/CF

-3.0658

PEG

0.1164

P/S

24.6423

EV Multiple

-2.1199

P/FV

1.2625

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation